drugset / Trial / NCT04327843

Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)

NCT04327843

NaSingle-groupOpen-labelTreatment

Summary

The proposed, three phase project will refine and test a first-ever care approach in SSA that combines LAI with a behavioral program specifically intended to promote medication adherence in chronic psychotic disorders (CPDs). In addition to the novel focus, innovative elements include: 1.) a manualized curriculum that targets specific barriers and facilitators to medication adherence in Tanzanians with CPD, 2.) targeting known, high-risk individuals with CPD (those who miss ≥20% of prescribed antipsychotic medication, and 3.) using existing injection clinic health workers to deliver the adherence promotion program. Strengths include the highly generalizable methods and use of LAIs that are available in low-resource settings.

Timeline

Start
2019-11-05
Primary completion
2020-07-30
Completion
2020-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Haloperidol Decanoate Small molecule Intramuscular